Pay in 4 interest-free payments of $23.80 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Mdivi-1 is a selective cell-permeable inhibitor of mitochondrial division dynamin-related GTPase (DRP1) and mitochondrial division dynamin I (Dnm1)
Brain Res Dev Brain Res
BX-471 was undergoing phase I trials for the potential treatment of autoimmune diseases
C4H4O4/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21
Gimeracil Size:Solid 2 mg Mdivi-1 is a selective cell-permeableGimeracil is a pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). Product information CAS Number: 103766 25 2 Molecular Weight: 145. 54 Formula: C5H4ClNO2
US$ 34.00
US$ 49.99
US$ 1505.40
US$ 7289.38
US$ 610.20
US$ 7158.46
US$ 418.99
US$ 63.99
US$ 16.00
US$ 7796.60
US$ 252.55
US$ 4854.71
US$ 3953.95
US$ 389.51
US$ 28.99
US$ 28.99